Azora Therapeutics, Inc. (DE)
- Close
- Oct 29, 2026 · +48000.00%
- Market cap
- $12.63M
- 2.63M shares
- Filings
- 583
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2021derived
—Q3 2026N/M FY25 yoy
Q3 2026+56.8% FY25 yoy
- $12.63M
- —
- —
- —
- —
- —
FY2025 figures · derived
Price
Oct 29, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,619,671 | reported | |
| FY 2024 | 2024-12-31 | $3,229,226 | reported | |
| FY 2023 | 2023-12-31 | $1,267,077 | reported | |
| FY 2022 | 2022-12-31 | $1,950,308 revised | reported | |
| FY 2021 | 2021-12-31 | $8,395,648 revised | reported | |
| FY 2020 | 2020-12-31 | $5,853,291 | reported | |
| FY 2019 | 2019-12-31 | $3,965,543 | reported | |
| FY 2018 | 2018-12-31 | $368,459 | reported | |
| FY 2017 | 2017-12-31 | $182,107 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $1.66K | $1.66K | — | 4.05M sh | −85.8% | — |
Pharmaceutical preparations
Azora Therapeutics, Inc. (DE) is the 406th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
OTLCOncotelic Therapeutics, Inc.———$13.7MMTNBMatinas BioPharma Holdings, Inc.———$13.7MLSTALisata Therapeutics, Inc.$170.0K83.0%9,756.5%$13.0MBIVIBiovie Inc.———$12.7M
AZRAzora Therapeutics, Inc. (DE) (this company)———$12.6M
NCELNewcelX Ltd.———$12.5MASBPAspire-Lakewood Holdings, Inc.$6.2K—394,725.1%$12.2MPTNPalatin Technologies Inc$13.2M—63.5%$12.2MONCOOnconetix, Inc.$815.4K67.7%1,721.0%$12.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR